- 5 Results
Lowest price: € 234.25, highest price: € 371.59, average price: € 304.49
1
Pharmacotherapy of Pulmonary Hypertension
Order
at Orellfuessli.ch
CHF 385.90
(aprox. € 371.59)
Shipment: € 17.331
Order
Provider details
Sponsored link

Pharmacotherapy of Pulmonary Hypertension - new book

ISBN: 9783642386640

This volume focuses on current evidence-based pharmacological treatments of various forms of pulmonary hypertension and provides a comprehensive review of the latest developments in this … More...

Nr. A1033198194. Shipping costs:Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage, , Sofort per Download lieferbar, zzgl. Versandkosten. (EUR 17.33)
close (x)
2
Pharmacotherapy of Pulmonary Hypertension - Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch
Order
at Springer.com
CHF 255.73
(aprox. € 234.25)
Order
Details & Shipping
Sponsored link

Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch:

Pharmacotherapy of Pulmonary Hypertension - new book

ISBN: 9783642386640

This volume focuses on current evidence-based pharmacological treatments of various forms of pulmonary hypertension and provides a comprehensive review of the latest developments in this … More...

new in stock CH:::0.00 EUR. Shipping costs:zzgl. Versandkosten., plus shipping costs
close (x)
3
Pharmacotherapy of Pulmonary Hypertension - Springer
Order
at Thalia.de
€ 319.93
Shipment: € 0.001
Order
Provider details
Sponsored link
Springer:
Pharmacotherapy of Pulmonary Hypertension - new book

2013

ISBN: 9783642386640

This volume focuses on current evidence-based pharmacological treatments of various forms of pulmonary hypertension and provides a comprehensive review of the latest developments in this … More...

Nr. 38576208. Shipping costs:, Sofort per Download lieferbar, DE. (EUR 0.00)
close (x)
4
Pharmacotherapy of Pulmonary Hypertension - Shonali Sabherwal
Order
at hive.co.uk
£ 233.33
(aprox. € 276.74)
Order
Details & Shipping
Sponsored link
Shonali Sabherwal:
Pharmacotherapy of Pulmonary Hypertension - new book

ISBN: 9783642386640

This book focuses on current, evidence-based pharmacological treatments of various forms of pulmonary hypertension and also provides a comprehensive review of recent developments in this … More...

No. 9783642386640. Shipping costs:Instock, Despatched same working day before 3pm, zzgl. Versandkosten., plus shipping costs
close (x)
5
Pharmacotherapy of Pulmonary Hypertension - Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch
Order
at lehmanns.de
€ 319.93
Shipment: € 0.001
Order
Provider details
Sponsored link
Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch:
Pharmacotherapy of Pulmonary Hypertension - new book

2013, ISBN: 9783642386640

eBooks, eBook Download (PDF), 2013, [PU: Springer Berlin], Springer Berlin, 2013

Shipping costs:Download sofort lieferbar. (EUR 0.00)
close (x)
1As some platforms do not transmit shipping conditions to us and these may depend on the country of delivery, the purchase price, the weight and size of the item, a possible membership of the platform, a direct delivery by the platform or via a third-party provider (Marketplace), etc., it is possible that the shipping costs indicated by euro-book.co.uk / euro-book.co.uk do not correspond to those of the offering platform.

Bibliographic data of the best matching book

Details of the book
Pharmacotherapy of Pulmonary Hypertension
Author:
Title:
ISBN:

9783642386640

Details of the book - Pharmacotherapy of Pulmonary Hypertension


EAN (ISBN-13): 9783642386640
ISBN (ISBN-10): 3642386644
Publishing year: 2013
Publisher: Springer Berlin
576 Pages
Language: eng/Englisch

Book in our database since 2012-03-01T00:35:45+00:00 (London)
Detail page last modified on 2022-08-31T07:52:56+01:00 (London)
ISBN/EAN: 9783642386640

ISBN - alternate spelling:
3-642-38664-4, 978-3-642-38664-0
Alternate spelling and related search-keywords:
Book author: johannes peter, humbert, stasch, johann peter, hum, stas peter, staß, marc peter
Book title: hype, hypertension

Information from Publisher

Author: Marc Humbert; Oleg V. Evgenov; Johannes-Peter Stasch
Title: Handbook of Experimental Pharmacology; Pharmacotherapy of Pulmonary Hypertension
Publisher: Springer; Springer Berlin
576 Pages
Publishing year: 2013-10-04
Berlin; Heidelberg; DE
Printed / Made in
Language: English
Available
IX, 576 p. 66 illus., 56 illus. in color.

EA; E107; eBook; Nonbooks, PBS / Medizin/Pharmazie; Pharmakologie; Verstehen; Vasoactive substances; WHO Group I-V; lung vasculature; pulmonary artery; pulmonary hypertension (PH); pulmonary vein; C; Pharmacology/Toxicology; Pharmaceutical Sciences/Technology; Internal Medicine; Pneumology/Respiratory System; Laboratory Medicine; Molecular Medicine; Pharmacology; Pharmaceutics; Internal Medicine; Pneumology; Biomedical Research; Biomedical and Life Sciences; Medizinische Chemie, Pharmazeutische Chemie; Klinische und Innere Medizin; Lungen- und Bronchialheilkunde; Medizinische Forschung; BB

Over the past decade, major advancements in the understanding of the molecular mechanisms and pathophysiology of pulmonary hypertension occurred in parallel with the discovery and development of new therapies. Pharmacological agents that modulate the main pathophysiological pathways of pulmonary arterial hypertension have changed the course of this devastating disease by relieving symptoms and improving and prolonging patients’ lives.

The first part of the book covers definition, classification, pathophysiology, pathology, biomarkers and animal models of pulmonary hypertension, thus laying the conceptual basis for what follows. The middle section provides an overview of the established therapies, such as calcium channel blockers, prostanoids, endothelin receptor antagonists, phosphodiesterase-5 inhibitors and inhaled nitric oxide. The concluding section explores novel pathways and emerging therapeutic approaches including soluble guanylate cyclase stimulators, Rho-kinase inhibitors, inhibitors of serotonin receptors and transporters, peptide growth factors, vasoactive peptides, modulators of redox equilibrium and cyclic nucleotides homeostasis, as well as immunosuppressive and anti-proliferative agents. Particular attention is given to clinical applications of these experimental therapies.

Preface.- Part I. Pulmonary hypertension: conceptual bases of the disease. Pulmonary hypertension: definition, classification, and epidemiology. Pulmonary hypertension: pathophysiology and signalling pathways. Pulmonary hypertension: pathology. Pulmonary hypertension: biomarkers. Pulmonary hypertension: animal models.- Part II. Pulmonary hypertension: established therapies. General supportive care. Calcium channel blockers. Prostacyclins. Endothelin receptor antagonists. Phosphodiesterase 5 inhibitors.- Part III. Pulmonary hypertension: novel pathways and emerging therapies     Soluble guanylate cyclase stimulators. Therapeutics targeting dysregulated redox equilibrium and endothelial dysfunction (NOXs, sGC activators, GSNOR). Rho-kinase inhibitors. Serotonin transporters and serotonin receptors. PDGF inhibitors. Novel anti-proliferative strategies beyond imatinib. Immunosuppressive agents. Vasoactive peptides. Inhibitors of cGMP/cAMP metabolism (MRP4, MRP5, PDE1). Old targets re-visited. Stem cells and cell based therapy.- Part IV. Conclusions and Outlook. Pulmonary hypertension: evidence-based management in the modern era and future directions.

Written by leading experts in the field of pulmonary hypertension

Broadens your understanding of current, evidence-based pharmacological treatments of various forms of pulmonary hypertension

Comprehensive review of most recent developments in this field including new signaling pathways

Includes supplementary material: sn.pub/extras


< to archive...